Spyre Therapeutics (NASDAQ:SYRE) filed a prospectus related to the proposed resale of 33.36 million common shares by the selling stockholders. This prospectus is not an offer to sell these securities....
Source LinkSpyre Therapeutics (NASDAQ:SYRE) filed a prospectus related to the proposed resale of 33.36 million common shares by the selling stockholders. This prospectus is not an offer to sell these securities....
Source Link
Comments